Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Panmure Liberum ups AB Foods to 'buy', shares spark

(Sharecast News) - Panmure Liberum upgraded Associated British Foods on Monday to 'buy' from 'hold' and hiked the price target to 2,600p from 1,900p as it said the market underestimates the pace of recovery of Sugar profits. Panmure said earnings in the sugar division are volatile and have a disproportionate impact on ABF's share price, which dissuades investors from buying the stock.

It argued that the sugar segment is a quality business that generates better returns than peers, but one that has material short-term earnings risks.

"We calculate that a carve-out of the ABF Sugar business could lead to an 13-15% higher value for shareholders, and a potential disposal could generate more," Panmure Liberum, said.

"However, we turn positive on ABF even with Sugar. We think the market underestimates the pace of recovery of Sugar profits, with actions already taken to address underperforming businesses."

Panmure also said the market underestimates the margin tailwinds at Primark, not just from FX but also efficiencies and operational leverage.

It forecasts a "potent" combination of 13% adjusted earnings per share compound annual growth rate over FY'25-28E, with around 7% per annum in dividends and buybacks.

At 1100 BST, the shares were up 3.6% at 2,121p.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.